发明名称 SOLID DOZED PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION CONTAINING COMBINATION OF METFORMIN AND GLIBENCLAMIDE
摘要 FIELD: medicine, pharmaceuticals, in particular compositions for treatment of insulin-independent II type diabetus mellitus. ^ SUBSTANCE: claimed composition represents single solid dosed pharmaceutical for oral administration and contains effective dose of metformin and glibenclamide, wherein said glibenclamide contains powdery particles with specific surface of 1.7-2.2 m2/g. Also disclosed are method for treatment of insulin-independent diabetes or hyperglycemia; method for providing and enhancing of glibenclamide bioavailability in human body (variants). ^ EFFECT: composition with increased glibenclamide bioavailability. ^ 68 cl, 3 ex, 7 tbl, 3 dwg
申请公布号 RU2286788(C2) 申请公布日期 2006.11.10
申请号 RU20030126257 申请日期 1999.07.12
申请人 LIFA 发明人 BONOMM IV;NIKOLSON DZHEFFRI;KEJV DZHILLIAN;NIKOLSON SARA DZH.
分类号 A61K9/20;A61K31/64;A61K;A61K9/00;A61K9/14;A61K9/16;A61K9/22;A61K9/24;A61K9/28;A61K9/48;A61K31/155;A61P3/10;A61P5/50 主分类号 A61K9/20
代理机构 代理人
主权项
地址